Michel Lagarde — Senior VP & President of Pharma Services at Thermo Fisher Scientific

Mr. Michel Lagarde has been President of Pharma Services and Senior Vice President at Thermo Fisher Scientific Inc. since August 2017. Mr. Lagarde has been President of Patheon Inc. since May 31, 2016. Mr. Lagarde serves as Chief Operating Officer of Patheon Inc. He joined Patheon from JLL Partners. Mr. Lagarde served as a Principal, Operating Partner and Managing Director of JLL Partners. He served as President of Patheon N.V. (also known as Patheon Holdings Co??peratief U.A.). For the last eight years, he has worked with several of JLL's portfolio companies in the healthcare and pharma services sectors as managing director, including Patheon. Mr. Lagarde joined JLL Partners in 2008. Mr. Lagarde served as the Chief Executive Officer and Chief Financial Officer at Domestic Appliances and Personal Care division of Philips Electronics North America. He served as the Chief Financial Officer of Philips Electronics Indonesia. He served as Finance Controller of Philips Electronics Hong Kong, where he was responsible for a $1 billion industrial footprint. He has been a Director of BioClinica, Inc. since March 13, 2013. He serves as a Director of Vicarius Pharma AG and American Dental Partners, Inc. He served as Director of Patheon N.V. (also known as Patheon Holdings Co??peratief U.A.) from December 15, 2011 to May 2016. He served as a Director of Patheon Inc. from 2011 to 2016. Mr. Lagarde received a B.B.A from European University Antwerp and an Executive Master in Finance and Control from the University of Maastricht & Amsterdam.